<DOC>
	<DOC>NCT00525512</DOC>
	<brief_summary>The objective of this study is to evaluate the effects on exercise duration of 96 weeks treatment with 18 mcg tiotropium (Spiriva HandiHaler) daily as compared to placebo, in patients with COPD.</brief_summary>
	<brief_title>Tiotropium In Exercise</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Inclusion criteria 1. All patients must sign an informed consent 2. Diagnosis of COPD with specific spirometric criteria (determined at study visits) 3. Age &gt;= 40 years 4. Medical Research Council Dyspnoea score &gt;= 2 5. Current or exsmoker with a &gt;= 10 packyear smoking history 6. Ability to exercise on treadmill Exclusion criteria 1. Significant diseases other than COPD such as history of lifethreatening pulmonary obstruction, thoracotomy with pulmonary resection, interstitial lung disease, CF, pulmonary thromboembolic disease, clinically evident bronchiectasis, active tuberculosis, or known moderate to severe renal impairment 2. Clinical history of asthma 3. Use of supplemental oxygen therapy 4. Respiratory tract infection or COPD exacerbation in the 6 weeks prior to Visit 1 or during the washout period prior to Visit 3 (may randomize 6 weeks after recovery) 5. Recent history (&lt;= 12 months) of myocardial infarction 6. Unstable or lifethreatening cardiac arrhythmia 7. Malignancy treated with radiation therapy or chemotherapy in the last 5 years 8. Pregnant or nursing women 9. Known hypersensitivity to anticholinergic drugs or any component of the study medications 10. Participation in pulmonary or cardiac rehab program within 13 weeks of Visit 1 11. Estimated life expectancy &lt; 2 years 12. Symptomatic prostatic hyperplasia or bladder neck obstruction 13. Known narrowangle glaucoma 14. Any condition that is contraindicated for exercise 15. Orthopaedic, muscular, neurological or cardiac disease that would interfere with regular participation in aerobic exercise or with exercise testing 16. Body mass index &lt; 18 kg/m2 or &gt;35 kg/m2 list truncated for space</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>